These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18666271)

  • 1. Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.
    Rai P; Vance D; Poon V; Mogridge J; Kane RS
    Chemistry; 2008; 14(26):7748-51. PubMed ID: 18666271
    [No Abstract]   [Full Text] [Related]  

  • 2. Raftlike polyvalent inhibitors of the anthrax toxin: modulating inhibitory potency by formation of lipid microdomains.
    Rai PR; Saraph A; Ashton R; Poon V; Mogridge J; Kane RS
    Angew Chem Int Ed Engl; 2007; 46(13):2207-9. PubMed ID: 17310484
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyvalent inhibitors of anthrax toxin that target host receptors.
    Basha S; Rai P; Poon V; Saraph A; Gujraty K; Go MY; Sadacharan S; Frost M; Mogridge J; Kane RS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13509-13. PubMed ID: 16938891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of monodisperse and well-defined polypeptide-based polyvalent inhibitors of anthrax toxin.
    Patke S; Boggara M; Maheshwari R; Srivastava SK; Arha M; Douaisi M; Martin JT; Harvey IB; Brier M; Rosen T; Mogridge J; Kane RS
    Angew Chem Int Ed Engl; 2014 Jul; 53(31):8037-40. PubMed ID: 24706570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.
    Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
    Bioconjug Chem; 2006; 17(5):1265-9. PubMed ID: 16984137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins.
    Rai P; Padala C; Poon V; Saraph A; Basha S; Kate S; Tao K; Mogridge J; Kane RS
    Nat Biotechnol; 2006 May; 24(5):582-6. PubMed ID: 16633350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of a heptavalent anthrax toxin inhibitor.
    Joshi A; Kate S; Poon V; Mondal D; Boggara MB; Saraph A; Martin JT; McAlpine R; Day R; Garcia AE; Mogridge J; Kane RS
    Biomacromolecules; 2011 Mar; 12(3):791-6. PubMed ID: 21302959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the anchor in polyethylene glycol-lipids on the transfection activity of PEGylated cationic liposomes encapsulating DNA.
    Kusumoto K; Akita H; El-Sayed A; Harashima H
    Biol Pharm Bull; 2012; 35(4):445-8. PubMed ID: 22466545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of peptide-based anthrax toxin inhibitors.
    Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
    Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
    Gujraty KV; Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
    Biomacromolecules; 2006 Jul; 7(7):2082-5. PubMed ID: 16827573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of lipid rafts: from model membranes to cells.
    Edidin M
    Annu Rev Biophys Biomol Struct; 2003; 32():257-83. PubMed ID: 12543707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
    Kibria G; Hatakeyama H; Harashima H
    Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase structure of liposome in lipid mixtures.
    Zhang T; Li Y; Mueller A
    Chem Phys Lipids; 2011 Nov; 164(8):722-6. PubMed ID: 21872581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids and lipid domains of the yeast vacuole.
    Tsuji T; Fujimoto T
    Biochem Soc Trans; 2018 Oct; 46(5):1047-1054. PubMed ID: 30242116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics and stability of lipid bilayers modulated by thermosensitive polypeptides, cholesterols, and PEGylated lipids.
    Lee H; Kim HR; Park JC
    Phys Chem Chem Phys; 2014 Feb; 16(8):3763-70. PubMed ID: 24429702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant.
    Anabousi S; Kleemann E; Bakowsky U; Kissel T; Schmehl T; Gessler T; Seeger W; Lehr CM; Ehrhardt C
    J Nanosci Nanotechnol; 2006; 6(9-10):3010-6. PubMed ID: 17048512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positioning lipid membrane domains in giant vesicles by micro-organization of aqueous cytoplasm mimic.
    Cans AS; Andes-Koback M; Keating CD
    J Am Chem Soc; 2008 Jun; 130(23):7400-6. PubMed ID: 18479139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.